المؤلفون: Ed Schuuring, Rik J. Scheper, Alfons J. M. Balm, Lorian Menkema, Adrian C. Begg, Coen R.N. Rasch, Maarten A. Wildeman, Paul J. van Diest, Nicola J. Armstrong, Leendert H. J. Looijenga, Jacqueline E. van der Wal, Marie Louise F. Van Velthuysen, Guido B. van den Broek, Michiel W. M. van den Brekel

المساهمون: Other departments, Ear, Nose and Throat, Pathology, CCA - Immuno-pathogenesis, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)

المصدر: International journal of cancer. Journal international du cancer, 124(11), 2643-2650. Wiley-Liss Inc.
International Journal of Cancer, 124(11), 2643-2650. Wiley-Liss Inc.
van den Broek, G B, Wildeman, M, Rasch, C R N, Armstrong, N, Schuuring, E M, Begg, A C, Looijenga, L H J, Scheper, R J, van der Wal, J E, Menkema, L, van Diest, P J, Balm, A J M, van Velthuysen, M L F & van den Brekel, M W M 2009, ' Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation ', International Journal of Cancer, vol. 124, no. 11, pp. 2643-2650 . https://doi.org/10.1002/ijc.24254Test
International Journal of Cancer, 124(11), 2643-2650. Wiley
International Journal of Cancer, 124, 2643-50
International Journal of Cancer, 124, 11, pp. 2643-50

مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, medicine.medical_treatment, Aetiology, screening and detection [ONCOL 5], prognostic analysis, Retinoblastoma Protein, head and neck cancers, PROGNOSTIC-SIGNIFICANCE, chemoradiation, Tissue microarray, P53 GENE STATUS, BCL-2 PROTEIN EXPRESSION, Anatomical pathology, Middle Aged, Prognosis, Combined Modality Therapy, Multidrug Resistance-Associated Protein 2, Treatment Outcome, Proto-Oncogene Proteins c-bcl-2, Head and Neck Neoplasms, immunohistochemistry, Carcinoma, Squamous Cell, Female, Multidrug Resistance-Associated Proteins, STAGE OROPHARYNX CARCINOMA, medicine.drug, Adult, ORGAN PRESERVATION, medicine.medical_specialty, molecular markers, RADIATION-THERAPY, Internal medicine, Biomarkers, Tumor, CONCURRENT CHEMORADIOTHERAPY, medicine, Humans, Aged, Cisplatin, business.industry, Head and neck cancer, Cancer, TISSUE MICROARRAYS, Hypoxia-Inducible Factor 1, alpha Subunit, medicine.disease, Head and neck squamous-cell carcinoma, RANDOMIZED-TRIAL, Radiation therapy, LARYNGEAL-CANCER, Concomitant, Multivariate Analysis, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa46815a20c59e7a585bbbc5e1cc843Test
https://doi.org/10.1002/ijc.24254Test

المؤلفون: van den Broek, Guido B., Wildeman, Maarten, Rasch, Coen R. N., Armstrong, Nicola, Schuuring, Ed, Begg, Adrian C., Looijenga, Leendert H. J., Scheper, Rik, van der Wal, Jacqueline E., Menkema, Lorian, van Diest, Paul J., Balm, Alfons J. M., van Velthuysen, Marie-Louise F., van den Brekel, Michiel W. M.

المصدر: van den Broek , G B , Wildeman , M , Rasch , C R N , Armstrong , N , Schuuring , E , Begg , A C , Looijenga , L H J , Scheper , R , van der Wal , J E , Menkema , L , van Diest , P J , Balm , A J M , van Velthuysen , M-L F & van den Brekel , M W M 2009 , ' Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation ' , International ....

مصطلحات موضوعية: head and neck cancers, molecular markers, chemoradiation, immunohistochemistry, prognostic analysis, STAGE OROPHARYNX CARCINOMA, BCL-2 PROTEIN EXPRESSION, P53 GENE STATUS, RADIATION-THERAPY, RANDOMIZED-TRIAL, LARYNGEAL-CANCER, PROGNOSTIC-SIGNIFICANCE, CONCURRENT CHEMORADIOTHERAPY, TISSUE MICROARRAYS, ORGAN PRESERVATION

العلاقة: https://research.rug.nl/en/publications/0a9e1822-bdcf-42b2-a00b-462ea18faa19Test

الإتاحة: https://doi.org/10.1002/ijc.24254Test
https://hdl.handle.net/11370/0a9e1822-bdcf-42b2-a00b-462ea18faa19Test
https://research.rug.nl/en/publications/0a9e1822-bdcf-42b2-a00b-462ea18faa19Test